68 related articles for article (PubMed ID: 29685878)
1. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
[No Abstract] [Full Text] [Related]
2. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
3. Temporal Trends and Factors Associated with Receipt of Post-mastectomy Radiation After Neoadjuvant Chemotherapy in Women with cT3 Breast Cancer.
Manik R; Grady CB; Elmore LC; Fieber JH; Freedman GM; Jankowitz RC; Tchou JC; Zhang JQ; Hubbard RA; Fayanju OM
Ann Surg Oncol; 2023 Oct; 30(11):6506-6515. PubMed ID: 37460741
[TBL] [Abstract][Full Text] [Related]
4. 21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgery.
Xie SJ; Wang RJ; Wu SG; Zhang FX
Breast; 2024 Apr; 74():103679. PubMed ID: 38367283
[TBL] [Abstract][Full Text] [Related]
5. Effects of postmastectomy radiotherapy on survival in different age groups for patients with T3N0M0 breast cancer.
He MT; Lu XX; Gou ZC
Breast; 2021 Dec; 60():247-254. PubMed ID: 34808436
[TBL] [Abstract][Full Text] [Related]
6. Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study.
Loap P; Kirova Y
Strahlenther Onkol; 2024 Apr; 200(4):320-324. PubMed ID: 38165456
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis.
Zhou P; Zhang WW; Bao Y; Wang J; Lian CL; He ZY; Wu SG
Breast; 2020 Dec; 54():319-327. PubMed ID: 33278648
[TBL] [Abstract][Full Text] [Related]
8. Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
Gill J; Yendamuri K; Chatterjee U; Yao S; Oladeru OT; Singh AK; Ma SJ
BMC Cancer; 2024 Apr; 24(1):461. PubMed ID: 38614979
[TBL] [Abstract][Full Text] [Related]
9. Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database.
Agarwal P; Moshier E; Ru M; Ohri N; Ennis R; Rosenzweig K; Mazumdar M
Cancer Control; 2018; 25(1):1073274818789355. PubMed ID: 30021466
[TBL] [Abstract][Full Text] [Related]
10. Does Post-Mastectomy Radiotherapy Confer Survival Benefits on Patients With 1-3 Clinically Positive Lymph Nodes Rendered Pathologically Negative After Neoadjuvant Systemic Chemotherapy: Consensus from A Pooled Analysis?
Alamoodi M
Eur J Breast Health; 2024 Apr; 20(2):81-88. PubMed ID: 38571693
[TBL] [Abstract][Full Text] [Related]
11. The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients.
Li Y; Kurian AW; Bondarenko I; Taylor JMG; Jagsi R; Ward KC; Hamilton AS; Katz SJ; Hofer TP
Breast Cancer Res Treat; 2017 Feb; 161(3):587-595. PubMed ID: 28012085
[TBL] [Abstract][Full Text] [Related]
12. Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.
Shumway DA; Griffith KA; Hawley ST; Wallner LP; Ward KC; Hamilton AS; Morrow M; Katz SJ; Jagsi R
Cancer; 2018 Jul; 124(13):2714-2723. PubMed ID: 29669187
[TBL] [Abstract][Full Text] [Related]
13. Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.
Afghahi A; Mathur M; Thompson CA; Mitani A; Rigdon J; Desai M; Yu PP; de Bruin MA; Seto T; Olson C; Kenkare P; Gomez SL; Das AK; Luft HS; Sledge GW; Sing AP; Kurian AW
J Oncol Pract; 2016 Jun; 12(6):e697-709. PubMed ID: 27221993
[TBL] [Abstract][Full Text] [Related]
14. Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques.
Salvestrini V; Valzano M; Meattini I; Becherini C; Visani L; Francolini G; Morelli I; Bertini N; Orzalesi L; Bernini M; Bianchi S; Simontacchi G; Livi L; Desideri I
Radiol Med; 2024 Apr; ():. PubMed ID: 38602657
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Review of Cranial Chordomas Using National Databases in the USA.
Hulou MM; Garcia CR; Slone SA; Dugan A; Lei F; Huang B; Pittman T; Villano JL
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e149-e159. PubMed ID: 31303332
[TBL] [Abstract][Full Text] [Related]
16. Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
Petkov VI; Miller DP; Howlader N; Gliner N; Howe W; Schussler N; Cronin K; Baehner FL; Cress R; Deapen D; Glaser SL; Hernandez BY; Lynch CF; Mueller L; Schwartz AG; Schwartz SM; Stroup A; Sweeney C; Tucker TC; Ward KC; Wiggins C; Wu XC; Penberthy L; Shak S
NPJ Breast Cancer; 2016; 2():16017. PubMed ID: 28721379
[TBL] [Abstract][Full Text] [Related]
17. Impact of Environmental Temperature on the Pathological Complete Response and Survival Outcomes of Breast Cancer: A NCDB and SEER study.
Gupta A; Gupta K; Roy AM; Attwood K; Gandhi A; Edge S; Takabe K; Repasky E; Yao S; Gandhi S
Res Sq; 2023 Mar; ():. PubMed ID: 37034618
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma
Visser LL; Elshof LE; Schaapveld M; van de Vijver K; Groen EJ; Almekinders MM; Bierman C; van Leeuwen FE; Rutgers EJ; Schmidt MK; Lips EH; Wesseling J
Clin Cancer Res; 2018 Aug; 24(15):3593-3601. PubMed ID: 29685879
[No Abstract] [Full Text] [Related]
19. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
[TBL] [Abstract][Full Text] [Related]
20. Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy.
Haque W; Verma V; Hatch S; Suzanne Klimberg V; Brian Butler E; Teh BS
Breast Cancer Res Treat; 2018 Aug; 170(3):559-567. PubMed ID: 29693228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
